| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |